urine analysis News
-
Reetoo made a wonderful appearance at CACLP
From March 28 to March 30, 2021, the 18th China International Laboratory Medicine and Blood Transfusion Instruments and Reagent Expo was successfully held at Chongqing International Expo Center. Reetoo Biotech carries 7 major types of specimen series products, including vaginal secretion detector, sperm quality analyzer, automatic chromosome microscopic image scanning system, automatic urine ...
-
Join us at AACC 2022
As a leading company for AI-Driven IVD equipments, Reetoo will be attending AACC (American Association for Clinical Chemistry), which will take place at the McCormick Place Convention Center in Chicago from July 26 to 28. We will bring our latest products to the exhibition as below, and look forward to meeting you at our booth #4060. RT-F600: Automatic Vaginal Secretion Analyzer ...
-
Start Lab 2021: Life Science winners announced
We take a look at the first round of winning Italian start-ups that joined this year’s edition of our competion. The chosen projects were those with the highest potential and most innovative ideas in the Life sciences sector, all assessed by our jury of experts. UniCredit Start Lab, UniCredit's business platform dedicated to innovation, now at its eighth year running, was once again an ...
-
Novosanis research grant
Research grant of (up to) € 25 000 in support of the most impactful proposal and (up to) 200 Colli-Pee urine collection devices for use with the project. Novosanis is offering a research grant exclusive to EACR members to stimulate innovative research in cancer biomarker detection using urine as a sample type. As urine sampling is easy, quick and non-invasive it has the potential to change ...
By Novosanis NV
-
Health & Wellness: What Urinalysis Could Say About Your Well-being
Most people would agree that only looking at your bank account once a year is a bad idea, yet when we look at our own health, the only data many of us collect is from a once-a-year checkup, in which doctors will run a series of laboratory tests. These tests are a single data point describing the very dynamic systems that are our bodies, which change throughout the year. In order to start ...
By Fluxergy
-
First Patient Dosed in UroGen Pharma’s Home Instillation Study of UGN-102 in Patients with Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (LG IR-NMIBC)
Study explores opportunity to shift from clinic to home instillation of this promising non-surgical treatment Potential to transform care and access to treatment for this growing patient population UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat urothelial and specialty cancers, today announced that the ...
-
GC-MS used successfully to identify bladder cancer from urine headspace
Bladder cancer is one of the most common cancers in the UK and a group of scientists have experimented with a new non-invasive way to potentially diagnose it in the future. As studies have previously indicated that volatile organic compounds specific to bladder cancer may exist in urine headspace, scientists have decided to research this further by analysing urine samples from two goups; ...
-
Clinical labs in the Czech Republic are using CE system Capel-205
Сapillary electrophoresis (CE) system Capel-205 was installed in Tomas Bata Hospital. It is the second CE instrument in the clinical labs in the Czech Republic. The main tasks for Capel-205 in the hospital’s biochemical laboratory are the determination of transferrin with percentage calculation of its disialo-form and analysis of patients’ urine samples for the presence of ...
-
Alternating Nucleix’s Bladder EpiCheck® With Standard Surveillance Can Reduce Burden on Patients and Healthcare Systems
SAN DIEGO & REHOVOT, Israel--(BUSINESS WIRE)--Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced the publication of an analysis highlighting that Bladder EpiCheck® can reduce both patient burden and healthcare system costs in the U.S. and European countries for low grade intermediate risk non-muscle invasive bladder cancer ...
By Nucleix Ltd.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you